55
Participants
Start Date
December 16, 2013
Primary Completion Date
January 6, 2025
Study Completion Date
January 6, 2025
Docetaxel
75 mg/m2 by vein on Day 1 of each 21 day cycle for a maximum of 3 cycles.
Erlotinib
150 mg by mouth daily continuously until the day before surgery.
Placebo
150 mg by mouth daily continuously until the day before surgery.
Questionnaires
Questionnaire completion at baseline, 14 days after treatment completion, and 8 weeks after surgery.
Phone Call
Phone call made to patient 1 time each year after the end of treatment visit.
Chemotherapy
Cisplatin 75 mg/m2 or Carboplatin AUC 6 mg.min/ml by vein on Day 1 of each 21 day cycle for a maximum of 3 cycles.
University of Texas MD Anderson Cancer Center, Houston
Collaborators (1)
Astellas Pharma Inc
INDUSTRY
The Kadoorie Charitable Foundations
OTHER
M.D. Anderson Cancer Center
OTHER